ATE49121T1 - Entzuendungshemmende zusammensetzungen und verfahren. - Google Patents

Entzuendungshemmende zusammensetzungen und verfahren.

Info

Publication number
ATE49121T1
ATE49121T1 AT86307505T AT86307505T ATE49121T1 AT E49121 T1 ATE49121 T1 AT E49121T1 AT 86307505 T AT86307505 T AT 86307505T AT 86307505 T AT86307505 T AT 86307505T AT E49121 T1 ATE49121 T1 AT E49121T1
Authority
AT
Austria
Prior art keywords
methods
inflammatory compositions
pharmaceutically acceptable
acceptable salt
antiinflammatory
Prior art date
Application number
AT86307505T
Other languages
English (en)
Inventor
Thomas Charles Crawford
Joseph George Lombardino
David Lee Larson
Original Assignee
Pfizer
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pfizer filed Critical Pfizer
Application granted granted Critical
Publication of ATE49121T1 publication Critical patent/ATE49121T1/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/54—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one sulfur as the ring hetero atoms, e.g. sulthiame
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/38—Heterocyclic compounds having sulfur as a ring hetero atom
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • Epidemiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Molecular Biology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicinal Preparation (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Medicines Containing Plant Substances (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
AT86307505T 1985-10-02 1986-10-01 Entzuendungshemmende zusammensetzungen und verfahren. ATE49121T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US8501926 1985-10-02
EP86307505A EP0218453B1 (de) 1985-10-02 1986-10-01 Entzündungshemmende Zusammensetzungen und Verfahren

Publications (1)

Publication Number Publication Date
ATE49121T1 true ATE49121T1 (de) 1990-01-15

Family

ID=22188870

Family Applications (1)

Application Number Title Priority Date Filing Date
AT86307505T ATE49121T1 (de) 1985-10-02 1986-10-01 Entzuendungshemmende zusammensetzungen und verfahren.

Country Status (15)

Country Link
US (1) US4994457A (de)
EP (1) EP0218453B1 (de)
JP (1) JPS6296424A (de)
KR (1) KR890001236B1 (de)
AT (1) ATE49121T1 (de)
AU (1) AU563822B2 (de)
CA (1) CA1273875A (de)
DE (1) DE3667914D1 (de)
DK (1) DK166343C (de)
GR (1) GR3000305T3 (de)
HU (1) HU207219B (de)
IE (1) IE58635B1 (de)
NZ (1) NZ217778A (de)
PT (1) PT83472B (de)
ZA (1) ZA867494B (de)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5436241A (en) * 1994-01-14 1995-07-25 Bristol-Myers Squibb Company Topical anti-inflammatory compositions containing piroxicam
US20070141181A1 (en) 1998-02-13 2007-06-21 Nutramax Laboratories, Inc. Use of anabolic agents, anti-catabolic agents, antioxidant agents, and analgesics for protection, treatment and repair of connective tissues in humans and animals
US6797289B2 (en) 1998-02-13 2004-09-28 Nutramax Laboratories, Inc. Use of anabolic agents, anti-catabolic agents, antioxidant agents, and analgesics for protection, treatment and repair of connective tissues in humans and animals
US6555141B1 (en) 1998-02-27 2003-04-29 Nutramax Laboratories, Inc. L-ergothioneine, Milk thistle, and S-adenosylmethionine for the prevention, treatment and repair of liver damage
US20010000472A1 (en) * 1998-02-27 2001-04-26 Nutramax Laboratories, Inc. L-ergothioneine, milk thistle, and s-adenosylmethionine for the prevention, treatment and repair of liver damage
US20030099722A1 (en) * 2001-10-09 2003-05-29 Baxter Jeffrey H. Methods and compositions for providing glutamine
PL2103306T3 (pl) * 2004-09-17 2012-12-31 Ajinomoto Kk Zastosowanie kwasu glutaminowego do zapobiegania/polepszania czynnościowego zaburzenia trawienia
KR101821050B1 (ko) 2015-10-14 2018-03-09 씨제이제일제당 (주) 바이오-기반 n-아세틸-l-메티오닌 및 이의 용도

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA1029660A (en) * 1973-06-01 1978-04-18 Kyowa Hakko Kogyo Co. Prevention of gastric lesions
GB2078738B (en) * 1980-06-27 1983-11-30 Mitsui Toatsu Chemicals Benzothiazine derivatives
JPS5714589A (en) * 1980-06-27 1982-01-25 Mitsui Toatsu Chem Inc Benzothiazine derivative, its preparation and drug composition
US4434163A (en) * 1981-06-01 1984-02-28 Pfizer Inc. Water-soluble benzothiazine dioxide salts
US4434164A (en) * 1981-06-01 1984-02-28 Pfizer Inc. Crystalline benzothiazine dioxide salts
US4486436A (en) * 1982-07-22 1984-12-04 Analgesic Associates Analgesic and anti-inflammatory compositions comprising caffeine and methods of using same
US4551452A (en) * 1983-12-21 1985-11-05 Pfizer Inc. Anti-inflammatory 2-methyl-2H-1,2-benzo-(or -thieno-)thiazine-3-carboxamide 1,1-dioxide derivatives, compositions, and method of use therefor
US4564614A (en) * 1984-10-11 1986-01-14 Pfizer Inc. Antiinflammatory methods
EP0178122B1 (de) * 1984-10-11 1991-06-05 Pfizer Inc. Piroxicam enthaltende entzündungshemmende Zusammensetzungen
US4559326A (en) * 1985-01-31 1985-12-17 Pfizer Inc. Antiinflammatory compositions and methods

Also Published As

Publication number Publication date
DK166343C (da) 1993-09-06
US4994457A (en) 1991-02-19
CA1273875A (en) 1990-09-11
HU207219B (en) 1993-03-29
DE3667914D1 (de) 1990-02-08
GR3000305T3 (en) 1991-06-07
DK468486A (da) 1987-04-03
AU6342186A (en) 1987-04-09
ZA867494B (en) 1988-05-25
KR890001236B1 (ko) 1989-04-28
HUT46216A (en) 1988-10-28
IE862599L (en) 1987-04-02
JPH0470285B2 (de) 1992-11-10
KR870003783A (ko) 1987-05-04
EP0218453B1 (de) 1990-01-03
DK468486D0 (da) 1986-10-01
JPS6296424A (ja) 1987-05-02
AU563822B2 (en) 1987-07-23
NZ217778A (en) 1989-03-29
PT83472B (pt) 1989-05-31
EP0218453A1 (de) 1987-04-15
DK166343B (da) 1993-04-13
IE58635B1 (en) 1993-10-20
PT83472A (en) 1986-11-01

Similar Documents

Publication Publication Date Title
IT1158025B (it) Derivati di 3-ammino pregn-5-ene e loro sali, procedimento per la loro preparazione, per l'applicazione come medicamenti e composizioni che li contengono
DE3667914D1 (de) Entzuendungshemmende zusammensetzungen und verfahren.
IT8419141A0 (it) Procedimento per la preparazione dell'estere metilico di alfa-l-aspartil-l-fenilalanina.
EG17890A (en) Improved antiinflammatory compositions and methods
IT1164180B (it) Derivati n-carbammoilici dell'isotiazolo-(5,4b)piridin-one-3 e loro procedimento di preparazione
IT8520463A0 (it) Trattamento dell'osteoporosi.
IT8321080A0 (it) Procedimento per la preparazione dell'estere metilico di alfa-l-aspartil-l-fenil-alanina.
IT1196494B (it) Derivati dell'acito cef-3-em-4-carbossilico,procedimento per la loro preparazione e composizioni farmaceutiche che li contengono
JPS6416755A (en) Manufacture of n-(3',4'-dimethoxycinnamoyl)-aniline derivative
DK310685D0 (da) 5,6-dihydro-4h-cyklopenta(b)-tiofen-6-karboxylsyrer, fremgangsmaadetil fremstilling af dem og laegemiddelpraeparat indeholdende dem
PT86665A (pt) Process for the preparation of 14,15-substituted lanosterols and of hypocholesterolemic compositions containing the same
IT8520448A0 (it) Trattamento dell'osteoporosi.
IT8047950A0 (it) Composizioni farmaceutiche impiegabili per il trattamento dell'ipertensione
IT1215261B (it) Composizioni farmaceutiche adattivita' antigalattopoietica.
ES8800666A1 (es) Procedimiento para la obtencion de derivados de 1,4-dihidropiridina
IT8520515A0 (it) Composizioni di farmaci eprocedimento per la loro preparazione.
PT88578A (pt) Process for the manufacture of 2,6-methanopyrrolo-3-benzazocines of intermediates useful for their manufacture and of pharmaceutical compositions containing them
IT8422148A0 (it) Procedimento per la preparazione dell'hopantenato di calcio.
IT8848388A0 (it) Composizione farmaceutica comprendente inosiplex e zidovudina per il trattamento dell'aids e sindromi correlate
IT8619873A0 (it) Procedimento per la preparazione di derivati dell'azetidinone.
IT8848444A0 (it) Composizione farmaceutica comprendente inosina,acido p-acetammidobenzoico e zidovudina per il trattamento dell'aids e sindromi correlate
IT8848445A0 (it) Composizione farmaceutica comprendente acido p-acetammidobenzoico e zidovudina per il trattamento dell'aids e sindromi correlate
ATE103279T1 (de) 2,3-thiomorpholinedion-2-oxim-derivate, arzneimittelzusammensetzungen und verfahren zur herstellung.
IT8420335A0 (it) Procedimento per la preparazione dell'ubidecarenone.
IT8223108A0 (it) Procedimento per la preparazione dell'isosorbide-5-nitrato.

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification
REN Ceased due to non-payment of the annual fee